Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular endothelial function refers to the complex physiological activity of the endothelium, the monolayer of cells lining the entire vascular system. It acts as a dynamic organ that maintains vascular homeostasis by regulating vascular tone, blood flow, leukocyte adhesion, and platelet aggregation through the secretion of various paracrine factors, most notably nitric oxide (NO) [1][2]. Endothelial dysfunction is characterized by a shift toward a pro-inflammatory, pro-thrombotic, and vasoconstrictive state, which serves as a critical early marker and driver of atherosclerosis and other cardiovascular diseases [2][3]. While not a single molecular target, improving endothelial function is a primary goal of many cardiovascular therapies, including statins, ACE inhibitors, and phosphodiesterase inhibitors, which work by enhancing NO signaling or reducing oxidative damage [3][4]. Clinical assessment of this function, often via flow-mediated dilation, provides valuable insights into a patient's cardiovascular risk and response to treatment [1][5]. Maintaining robust endothelial function is essential for preventing end-organ damage in conditions like hypertension and diabetes [1][3]. Sources: [1] StatPearls: Physiology, Endothelium (https://www.ncbi.nlm.nih.gov/books/NBK537233/); [2] Circulation: Endothelial Function and Cardiovascular Disease (https://www.ahajournals.org/doi/10.1161/01.CIR.0000128203.31223.4E); [3] Nature Reviews Cardiology: Endothelial dysfunction in cardiovascular disease (https://www.nature.com/articles/s41569-020-0407-5); [4] Journal of the American College of Cardiology: Endothelial Function as a Functional Expression of Cardiovascular Risk (https://www.jacc.org/doi/10.1016/j.jacc.2011.10.879); [5] PubMed: Assessment of endothelial function (https://pubmed.ncbi.nlm.nih.gov/15136432/).
Drugs improve vascular endothelial function by increasing the bioavailability of nitric oxide (NO), reducing oxidative stress, or inhibiting vasoconstrictor pathways such as the renin-angiotensin-aldosterone system (RAAS) and endothelin-1 signaling [3][4].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular endothelial function.